Covington Guides Salix's $2.6B Gastro Drugmaker Buy
North Carolina-based Salix Pharmaceuticals Ltd. struck a $2.6 billion merger deal to gobble up the gastroenterology-focused drug company Santarus Inc., to help solidify Salix's position in the niche market, the company...To view the full article, register now.
Already a subscriber? Click here to view full article